129
Views
16
CrossRef citations to date
0
Altmetric
Drug Profile

Certolizumab pegol: a new biologic targeting rheumatoid arthritis

&
Pages 855-866 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Paola Cipriani, Piero Ruscitti, Francesco Carubbi, Vasiliki Liakouli & Roberto Giacomelli. (2014) Methotrexate: an old new drug in autoimmune disease. Expert Review of Clinical Immunology 10:11, pages 1519-1530.
Read now
Yoshiya Tanaka, Kazuhiko Yamamoto, Tsutomu Takeuchi, Hisashi Yamanaka, Naoki Ishiguro, Katsumi Eguchi, Akira Watanabe, Hideki Origasa, Toshiharu Shoji, Nobuyuki Miyasaka & Takao Koike. (2014) Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: 52-week results from an open-label extension of the J-RAPID study. Modern Rheumatology 24:5, pages 734-743.
Read now

Articles from other publishers (14)

Patrick L. Iversen, Nicholas Kipshidze, Nodar Kipshidze, George Dangas, Eduardo Ramacciotti, Zurab Kakabadze & Jawed Fareed. (2023) A novel therapeutic vaccine targeting the soluble TNFα receptor II to limit the progression of cardiovascular disease: AtheroVax™. Frontiers in Cardiovascular Medicine 10.
Crossref
Jülide Hazal Özdemir, Şule Pınar Cinfer & Afife Binnaz Yoruç Hazar. 2023. Handbook of Polymers in Medicine. Handbook of Polymers in Medicine 219 242 .
Annamaria Sandomenico, Jwala P. Sivaccumar & Menotti Ruvo. (2020) Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments. International Journal of Molecular Sciences 21:17, pages 6324.
Crossref
Xiaobing Li, William J. Jusko & Yanguang Cao. (2018) Role of Interstitial Fluid Turnover on Target Suppression by Therapeutic Biologics Using a Minimal Physiologically Based Pharmacokinetic Model. Journal of Pharmacology and Experimental Therapeutics 367:1, pages 1-8.
Crossref
J.K. Durand & A.S. Baldwin. 2017. Chromatin Proteins and Transcription Factors as Therapeutic Targets. Chromatin Proteins and Transcription Factors as Therapeutic Targets 77 115 .
Ricardo Prado Golmia, Ayk Helena Barbosa Martins & Morton Scheinberg. (2014) When anti-TNF fails, anti-IL12-23 is an alternate option in psoriasis and psoriatic arthritis. Revista Brasileira de Reumatologia (English Edition) 54:3, pages 247-249.
Crossref
Ricardo Prado Golmia, Ayk Helena Barbosa Martins & Morton Scheinberg. (2014) Quando anti‐TNF não obtém sucesso, anti‐IL‐12‐23 é opção alternativa na psoríase e na artrite psoriásica. Revista Brasileira de Reumatologia 54:3, pages 247-249.
Crossref
Akshay Srivastava, Iain B. O’Connor, Abhay Pandit & J. Gerard Wall. (2014) Polymer-antibody fragment conjugates for biomedical applications. Progress in Polymer Science 39:2, pages 308-329.
Crossref
Venkat Ratnam Devadasu, Vivekanand Bhardwaj & M. N. V. Ravi Kumar. (2012) Can Controversial Nanotechnology Promise Drug Delivery?. Chemical Reviews 113:3, pages 1686-1735.
Crossref
Fabiola Atzeni, Piercarlo Sarzi-Puttini, Costantino Botsios, Antonio Carletto, Paola Cipriani, Ennio Giulio Favalli, Elena Frati, Valentina Foschi, Stefania Gasparini, AnnaRita Giardina, Elisa Gremese, Florenzo Iannone, Marco Sebastiani, Tamara Ziglioli, Domenico Biasi, Clodoveo Ferri, Mauro Galeazzi, Roberto Gerli, Roberto Giacomelli, Roberto Gorla, Marcello Govoni, Giovanni Lapadula, Antonio Marchesoni, Fausto Salaffi, Leonardo Punzi, Giovanni Triolo & Gianfranco Ferraccioli. (2012) Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry. Autoimmunity Reviews 12:2, pages 225-229.
Crossref
Fabiola Atzeni, Piercarlo Sarzi-Puttini, Roberto Gorla, Antonio Marchesoni & Roberto Caporali. (2011) Switching rheumatoid arthritis treatments: An update. Autoimmunity Reviews 10:7, pages 397-403.
Crossref
A. Perdriger. 2011. Conférences d'enseignement 2011. Conférences d'enseignement 2011 269 277 .
Yutaka Ikeda & Yukio Nagasaki. 2012. Polymers in Nanomedicine. Polymers in Nanomedicine 115 140 .
Olaf Schultz, Frank Oberhauser, Jasemine Saech, Andrea Rubbert-Roth, Moritz Hahn, Wilhelm Krone & Matthias Laudes. (2010) Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases. PLoS ONE 5:12, pages e14328.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.